5 Stocks Dragging In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 3 points (0.0%) at 16,165 as of Thursday, Dec. 19, 2013, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,090 issues advancing vs. 1,843 declining with 148 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.2%. On the negative front, top decliners within the industry include Insulet Corporation ( PODD), down 4.2%, DexCom ( DXCM), down 4.0%, Community Health Systems ( CYH), down 2.3%, Tenet Healthcare ( THC), down 2.1% and Universal Health Services ( UHS), down 1.7%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Intuitive Surgical ( ISRG) is one of the companies pushing the Health Services industry lower today. As of noon trading, Intuitive Surgical is down $3.79 (-1.1%) to $357.45 on light volume. Thus far, 113,081 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 471,700 shares. The stock has ranged in price between $355.25-$359.62 after having opened the day at $359.41 as compared to the previous trading day's close of $361.24.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $13.5 billion and is part of the health care sector. The company has a P/E ratio of 21.3, above the S&P 500 P/E ratio of 17.7. Shares are down 27.4% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Intuitive Surgical a buy, 4 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Aetna ( AET) is down $0.64 (-1.0%) to $66.42 on light volume. Thus far, 685,770 shares of Aetna exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $66.24-$66.93 after having opened the day at $66.71 as compared to the previous trading day's close of $67.07.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $24.2 billion and is part of the health care sector. The company has a P/E ratio of 13.3, below the S&P 500 P/E ratio of 17.7. Shares are up 44.8% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Medtronic ( MDT) is down $0.42 (-0.7%) to $57.34 on light volume. Thus far, 1.2 million shares of Medtronic exchanged hands as compared to its average daily volume of 3.8 million shares. The stock has ranged in price between $57.09-$57.48 after having opened the day at $57.43 as compared to the previous trading day's close of $57.76.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $56.5 billion and is part of the health care sector. The company has a P/E ratio of 15.1, below the S&P 500 P/E ratio of 17.7. Shares are up 40.8% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Medtronic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Baxter International ( BAX) is down $0.52 (-0.8%) to $66.72 on light volume. Thus far, 904,283 shares of Baxter International exchanged hands as compared to its average daily volume of 3.8 million shares. The stock has ranged in price between $66.48-$67.42 after having opened the day at $67.22 as compared to the previous trading day's close of $67.24.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $35.6 billion and is part of the health care sector. The company has a P/E ratio of 16.6, below the S&P 500 P/E ratio of 17.7. Shares are up 0.9% year to date as of the close of trading on Wednesday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is down $0.43 (-0.6%) to $67.55 on light volume. Thus far, 900,975 shares of Express Scripts exchanged hands as compared to its average daily volume of 4.9 million shares. The stock has ranged in price between $67.20-$67.98 after having opened the day at $67.98 as compared to the previous trading day's close of $67.98.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $53.9 billion and is part of the health care sector. The company has a P/E ratio of 29.0, above the S&P 500 P/E ratio of 17.7. Shares are up 23.9% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Scripts Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%